Highlights
Labcorp Receives FDA De Novo Marketing Authorization for PGDx elioâ„¢ plasma focusÂ
PGDx elio™ plasma focus Dx is the industry's first and only kitted, pan-solid tumor liquid biopsy test tha
Discussion Paper: Health Equity For Medical Devices
The U.S. Food and Drug Administration's (FDA's) Center for Devices and Radiological Health (CDRH) has develop
Q2/2024 Life Science Law Update – Key developments for pharma & device companies in
Q2/24 Life Science and Health Care Law Updates by Hogan Lovells including key trends in the EU and Big Five (France,
Cleveland Clinic announces new quantum computing and AI fellowship
Offered in partnership with Novo Nordisk Foundation, the fellowship will focus on technologies that analyze vast amounts
The growing practice of prescribing medical devices via telemedicine
UpScriptHealth specializes in this approach to virtual care, including for female pelvic health and opioid withdrawal sy
Japan's PMDA expands influence with new office in Thailand
<p>On 1 July 2024, Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) announced the establishment of
Dana-Farber Cancer Institute shares lessons on using secure LLMs
The Boston health system's director of AI operations discusses some challenges and best practices for integrating la
AI, automation offer relief for overburdened lab workers
Prolonged understaffing in clinical laboratories threatens to compromise patient care, but deployment of automation and
Epic moves forward on health app interoperability
Patients can now release all their electronic health data to apps of their choice through TEFCA's record location se
Risk Management in Medical Devices: Harmonizing ISO 14971-2019 & FDAÂ QMSR
nsuring the safety and efficacy of medical devices/IVDs is paramount in the healthcare industry. This critical object
Third ransomware attack on blood suppliers in 3 months
OneBlood has been hit by ransomware, resulting in a massive disruption to patient care. AHA urges health systems and hos
HIMSSCast: A pro checks in on the status of the health IT stock market
A comprehensive look at the market by Shahab Vagefi, managing director in Thomas H. Lee Partners' healthcare vertica